Skip to main content

Advertisement

SpringerLink
Log in

The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada

  • Meeting Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

CAR:

Chimeric antigen receptor

CCIC:

Canadian Cancer Immunotherapy Consortium

CRISPR:

Clustered regularly interspaced short palindromic repeats

CTLA4:

Cytotoxic T lymphocyte-associated protein-4

DC:

Dendritic cell

FZD5:

Frizzled class receptor 5

HER2:

Human epidermal growth factor receptor-2

IFN:

Interferon

IL:

Interleukin

IRE-1:

Inositol-requiring enzyme-1

MEK:

Mitogen-activated protein kinase

MHC:

Major histocompatibility complex

NK:

Natural killer

NKT:

Natural killer T

PD-1:

Programmed cell death protein-1

PD-L:

Programmed death ligand

RAS:

RAS-type GTPase family

RGMb:

Repulsive guidance molecule b

RNF43:

Ring finger protein 43

TAC:

T cell antigen coupler

TEX:

Tumor-derived exosomes

TIL:

Tumor-infiltrating lymphocytes

TIM-3:

T cell immunoglobulin and mucin domain 3

TME:

Tumor microenvironment

T-Vec:

Talimogene laherparepvec

VSV:

Vesicular stomatitis virus

XBP1:

X-box binding protein-1

Author information

Authors and Affiliations

  1. Deeley Research Centre, British Columbia Cancer Agency, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada

    Maartje C. A. Wouters

  2. Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada

    Céline M. Laumont

  3. Department of Laboratory Medicine and Pathobiology, Toronto General Research Institute, University of Toronto, Princess Margaret Cancer Research Tower 2-701, 101 College St, Toronto, ON, M5G 1L7, Canada

    Branson Chen

  4. Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

    Seong Jun Han

  5. Department of Biomedical Sciences, University of Guelph, 50 Stone Road E., Guelph, ON, N1G 2W1, Canada

    Kathy Matuszewska

  6. Department of Oncology, Faculty of Medicine and Dentistry, Cancer Research Institute of Northern Alberta (CRINA), University of Alberta, 116 St. and 85 Ave., Edmonton, AB, T6G 2R3, Canada

    Kyle Potts

  7. Departments of Pathology and Microbiology & Immunology, Dalhousie University, Sir Charles Tupper Medical Building, 5850 College Street, Halifax, NS, B3H 4R2, Canada

    Jeanette E. Boudreau

  8. Departments of Microbiology and Immunology and Physiology, Goodman Cancer Research Center, McIntyre Building, Room 705B McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada

    Connie. M. Krawczyk

  9. Department of Immunology, University of Toronto, University Health Network, 610 University Ave., Toronto, ON, M5G 2M9, Canada

    Seong Jun Han

Authors
  1. Maartje C. A. Wouters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Céline M. Laumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Branson Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seong Jun Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kathy Matuszewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyle Potts
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jeanette E. Boudreau
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Connie. M. Krawczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Connie. M. Krawczyk.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest. Connie Krawczyk participated in the organization of this meeting as coordinator of knowledge dissemination and outreach.

Additional information

Maartje C. A. Wouters, Jeanette E. Boudreau, and Connie. M. Krawczyk contributed equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wouters, M.C.A., Laumont, C.M., Chen, B. et al. The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada. Cancer Immunol Immunother 66, 811–818 (2017). https://doi.org/10.1007/s00262-017-1996-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-017-1996-9

Keywords

Search

Navigation